SJS Investment Consulting’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$558K Sell
3,900
-98
-2% -$13.8K 0.06% 84
2026
Q1
$524K Buy
3,998
+316
+9% +$45.4K 0.06% 78
2025
Q4
$489K Buy
3,682
+113
+3% +$15K 0.06% 77
2025
Q3
$468K Buy
3,569
+3,556
+27,354% +$485K 0.06% 77
2025
Q2
$1.73K Sell
13
-21
-62% -$2.41K ﹤0.01% 620
2025
Q1
$3.73K Buy
34
+14
+70% +$1.69K ﹤0.01% 534
2024
Q4
$2.48K Sell
20
-291
-94% -$35.3K ﹤0.01% 619
2024
Q3
$34K Hold
311
0.01% 227
2024
Q2
$34.3K Sell
311
-25
-7% -$2.76K 0.01% 210
2024
Q1
$38.1K Buy
336
+25
+8% +$2.57K 0.01% 213
2023
Q4
$30.3K Sell
311
-1
-0.3% -$92 0.01% 204
2023
Q3
$30.1K Sell
312
-4
-1% -$381 0.01% 201
2023
Q2
$28.6K Buy
316
+3
+1% +$252 0.01% 193
2023
Q1
$27.3K Sell
313
-21
-6% -$1.83K 0.01% 198
2022
Q4
$32.1K Sell
334
-235
-41% -$21.1K 0.01% 186
2022
Q3
$42K Buy
+569
New +$47.3K 0.01% 174
2022
Q1
$61K Buy
618
+31
+5% +$2.94K 0.02% 167
2021
Q4
$55K Buy
+587
New +$55.3K 0.02% 165

Other funds holding EMR

SJS Investment Consulting's EMR Position: Q2 2026 in Review

SJS Investment Consulting reduced its Emerson Electric (EMR) stake by 2.5% in Q2 2026, selling an estimated $13.8K and leaving 3,900 shares worth $558K. The position accounts for 0.06% of the portfolio, ranked #84.

SJS Investment Consulting first reported a position in EMR in Q4 2021 and has held it in 18 quarters since. 906 funds tracked by Wall St. Rank hold EMR as of Q2 2026.

  • SJS Investment Consulting held 3,900 shares of Emerson Electric worth $558K as of Q2 2026.
  • SJS Investment Consulting sold 98 Emerson Electric shares in Q2 2026, an estimated $13.8K.
  • Emerson Electric made up 0.06% of SJS Investment Consulting's portfolio in Q2 2026, its #84 holding.
  • SJS Investment Consulting first reported a position in Emerson Electric in Q4 2021 and has held it in 18 quarters since.
  • 906 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.